J B Chemicals & Pharmaceuticals Ltd

J B Chem & Pharm Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

J B Chemicals & Pharmaceuticals Ltd

₹ 1,825 2.29%
24 Apr 3:03 p.m.
jbpharma.com BSE: 506943 NSE : JBCHEPHARM
About

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]

Key Points

Revenue Split H1FY24
Domestic Formulations - 55%
Export Formulations - 30%
Contract Manufacturing - 13%
APIs - 2% [1]

Website BSE NSE
  • Market Cap ₹ 28,323 Cr.
  • Current Price ₹ 1,825
  • High / Low ₹ 1,940 / 875
  • Stock P/E 56.0
  • Book Value ₹ 173
  • Dividend Yield 0.50 %
  • ROCE 21.7 %
  • ROE 17.0 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 33.1%

Cons

  • Stock is trading at 10.5 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
500 490 546 527 533 584 716 740 729 699 853 837 800
334 364 388 412 419 462 548 574 559 538 618 602 585
Operating Profit 167 126 158 115 114 122 168 166 169 161 235 235 215
OPM % 33% 26% 29% 22% 21% 21% 23% 22% 23% 23% 28% 28% 27%
56 25 13 20 4 2 1 2 3 3 5 7 7
Interest 1 1 1 1 1 2 6 8 9 12 11 9 12
Depreciation 17 16 17 15 17 22 26 28 28 31 31 32 33
Profit before tax 204 134 153 118 101 100 137 132 136 122 198 201 176
Tax % 26% 24% 25% 25% 26% 17% 26% 26% 26% 27% 27% 28% 27%
152 103 115 88 75 83 101 98 101 89 145 145 128
EPS in Rs 9.81 6.63 7.46 5.72 4.82 5.35 6.55 6.32 6.54 5.73 9.34 9.36 8.25
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
686 816 957 1,061 1,144 1,175 1,250 1,501 1,641 1,892 2,190 2,884 3,189
618 705 802 868 917 952 1,050 1,209 1,270 1,340 1,681 2,219 2,343
Operating Profit 68 111 154 193 226 222 199 292 370 552 509 665 846
OPM % 10% 14% 16% 18% 20% 19% 16% 19% 23% 29% 23% 23% 27%
787 26 -27 10 55 46 39 37 37 116 39 9 22
Interest 24 5 6 7 10 5 3 5 3 7 5 34 44
Depreciation 22 24 27 38 40 46 56 55 65 67 71 112 126
Profit before tax 809 108 94 159 231 217 179 269 340 594 471 527 697
Tax % 21% 21% 27% 29% 22% 20% 29% 32% 21% 25% 23% 26%
643 85 68 114 179 173 128 182 268 447 361 389 506
EPS in Rs 37.94 5.01 4.04 6.70 10.57 10.20 7.66 11.34 17.34 28.92 23.35 25.12 32.68
Dividend Payout % 54% 30% 37% 105% 24% 5% 13% 22% 32% 29% 35% 35%
Compounded Sales Growth
10 Years: 13%
5 Years: 18%
3 Years: 21%
TTM: 15%
Compounded Profit Growth
10 Years: 19%
5 Years: 32%
3 Years: 15%
TTM: 32%
Stock Price CAGR
10 Years: 37%
5 Years: 59%
3 Years: 40%
1 Year: 73%
Return on Equity
10 Years: 15%
5 Years: 18%
3 Years: 19%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 17 17 17 17 17 17 17 16 15 15 15 15 16
Reserves 937 992 1,031 999 1,206 1,371 1,437 1,469 1,430 1,791 2,088 2,427 2,668
70 50 93 105 175 49 28 26 29 39 52 547 425
149 214 201 327 244 248 285 283 337 355 382 480 608
Total Liabilities 1,173 1,273 1,342 1,449 1,641 1,684 1,767 1,793 1,811 2,200 2,538 3,470 3,716
241 294 282 301 369 609 570 552 583 565 1,204 1,822 1,841
CWIP 39 5 46 55 135 4 17 15 16 26 19 55 72
Investments 338 434 536 598 612 544 567 589 536 811 146 339 458
555 540 477 495 525 528 613 636 676 799 1,170 1,254 1,346
Total Assets 1,173 1,273 1,342 1,449 1,641 1,684 1,767 1,793 1,811 2,200 2,538 3,470 3,716

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
851 80 -12 143 171 178 116 193 272 335 147 629
-236 -112 -139 -122 -52 -42 -24 -28 24 -231 4 -956
-526 -31 12 -23 -97 -165 -59 -156 -305 -87 -138 343
Net Cash Flow 88 -62 -138 -2 22 -30 32 9 -10 18 13 16

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 70 87 95 85 85 82 88 73 77 72 86 66
Inventory Days 124 97 108 109 108 131 134 142 149 163 172 136
Days Payable 46 56 50 53 56 65 76 76 97 96 96 78
Cash Conversion Cycle 148 128 152 141 137 149 145 139 128 139 162 124
Working Capital Days 108 84 105 60 94 95 107 98 88 95 130 100
ROCE % 8% 9% 13% 14% 17% 12% 9% 17% 22% 32% 22% 22%

Shareholding Pattern

Numbers in percentages

38 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
55.91% 55.91% 54.00% 54.00% 54.00% 53.96% 53.95% 53.93% 53.91% 53.86% 53.83% 53.78%
8.37% 8.74% 9.12% 9.22% 8.85% 8.66% 8.81% 8.62% 9.53% 10.05% 10.35% 11.06%
13.13% 15.23% 16.26% 16.89% 17.80% 18.47% 18.55% 19.08% 18.65% 18.58% 18.53% 18.38%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%
22.58% 20.12% 20.62% 19.89% 19.35% 18.91% 18.72% 18.35% 17.90% 17.50% 17.27% 16.78%
No. of Shareholders 70,74071,78864,86161,31460,26858,62959,77956,63355,96560,81763,23063,892

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls